Validation of a New Simplified Scoring System for Acute Calculous Cholecystitis
ACME
1 other identifier
observational
387
1 country
1
Brief Summary
Acute calculous cholecystitis (ACC) is the second most frequent surgical condition in emergency departments. The recommended treatment is surgical treatment (ST) and the accepted mortality is \<1%, but in severe and/or fragile patients is higher. Despite the Tokyo Guidelines, there no consensus on who is the unfit patient for ST. A recent study has identified 4 risk factors that predicts the mortality in a 92% of patients (ACME) and could help to develop new guidelines in ACC. The aim of this study is this validation of the new simplified scoring system for mortality in ACC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2021
CompletedFirst Submitted
Initial submission to the registry
January 10, 2024
CompletedFirst Posted
Study publicly available on registry
January 19, 2024
CompletedJanuary 23, 2024
January 1, 2024
4 months
January 10, 2024
January 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality
Evaluate the mortality in the cohort
2017 and 2021
Secondary Outcomes (1)
Complications
2017 and 2021
Eligibility Criteria
All the admisions with the inclusion criteria during 2017 and 2021.
You may qualify if:
- The selected patients were among those who had acute cholecystitis according to the TG18 or received a diagnosis of ACC in the histopathological report.
You may not qualify if:
- The study case definition was a "Pure ACC", therefore, patients with any other concomitant diagnosis potentially influencing outcome such as acute pancreatitis, acalculous cholecystitis, chronic cholecystitis, acute cholangitis, postoperative cholecystitis, gallbladder adenocarcinoma and those who had undergone cholecystectomy as a prophylactic measure in another intervention were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital del Marlead
Study Sites (1)
Ana María González Castillo
Cerdanyola del Vallès, Barcelona, 08290, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
January 10, 2024
First Posted
January 19, 2024
Study Start
January 8, 2021
Primary Completion
May 1, 2021
Study Completion
December 17, 2021
Last Updated
January 23, 2024
Record last verified: 2024-01